| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
| 01/10/1996 | EP0620822A4 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system. |
| 01/10/1996 | EP0529088B1 NOVEL PLASMID pBUL1 DERIVED FROM LACTOBACILLUS AND DERIVATIVE THEREOF |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/10/1996 | CN1114685A Human interleukin-2 immunotoxin |
| 01/10/1996 | CN1030643C Separation method and separating agent |
| 01/09/1996 | US5482928 Biocidal proteins |
| 01/09/1996 | US5482858 Polypeptide linkers for production of biosynthetic proteins |
| 01/09/1996 | US5482856 Production of chimeric antibodies by homologous recombination |
| 01/09/1996 | US5482853 Nuclear sequence for cellular genomes |
| 01/09/1996 | US5482852 Biologically safe plant transformation system |
| 01/09/1996 | US5482850 Method for identifying anti-parasitic compounds |
| 01/09/1996 | US5482847 Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said trasnformants |
| 01/09/1996 | US5482846 genetically engineered bacillus transformed with Zymomonas mobilis genes encoding alcohol dehydrogenase and pyruvate decarboxylase; bioethanol |
| 01/09/1996 | US5482845 Method for construction of normalized cDNA libraries |
| 01/09/1996 | US5482843 Culture of streptomyces to form chitosanase to form protein derivative |
| 01/09/1996 | US5482837 Methods of identifying lymphocytes with mutator phenotypes |
| 01/09/1996 | US5482836 DNA purification by triplex-affinity capture and affinity capture electrophoresis |
| 01/09/1996 | US5482835 Methods of testing in yeast cells for agonists and antagonists of mammal G-protein coupled receptors |
| 01/09/1996 | US5482713 Equine herpesvirus recombinant poxvirus vaccine |
| 01/09/1996 | US5482709 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 01/09/1996 | US5482708 Leukemia, proteins are not adjacent in native protein |
| 01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
| 01/04/1996 | WO1996000299A1 Nucleic acid fragments, derivatives of the mycobacterium xenopi genome, and applications thereof |
| 01/04/1996 | WO1996000298A1 Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 01/04/1996 | WO1996000297A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 01/04/1996 | WO1996000295A1 Targeted gene delivery system |
| 01/04/1996 | WO1996000294A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | WO1996000293A1 Heat-stable prolylendopeptidase |
| 01/04/1996 | WO1996000292A1 Modified pseudomonas lipases and their use |
| 01/04/1996 | WO1996000291A1 Genetic control of plant hormone levels and plant growth |
| 01/04/1996 | WO1996000290A1 Purified polyporus laccases and nucleic acids encoding same |
| 01/04/1996 | WO1996000289A1 Protocadherin proteins and their uses |
| 01/04/1996 | WO1996000288A2 Class bi and ci scavenger receptors |
| 01/04/1996 | WO1996000287A1 Dna coding for caldecrin and process for producing caldecrin by using the dna |
| 01/04/1996 | WO1996000286A1 Antisense nucleic acid compound |
| 01/04/1996 | WO1996000285A1 Novel animals and cell lines |
| 01/04/1996 | WO1996000282A1 Expression cassettes useful in construction of integrative and replicative expression vectors for streptomyces |
| 01/04/1996 | WO1996000242A1 Retinoic acid receptor epsilon |
| 01/04/1996 | WO1996000240A1 Novel protein and process for producing the same |
| 01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
| 01/04/1996 | WO1996000231A1 Anti-sense oligonucleotides for aromatase inhibition |
| 01/04/1996 | WO1996000084A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 01/04/1996 | WO1996000006A1 Inducible nitric oxide synthase gene for treatment of disease |
| 01/04/1996 | WO1996000002A1 Mutant dwarfism gene of petunia |
| 01/04/1996 | WO1995033059A3 Receptor for oncostatin m |
| 01/04/1996 | WO1995033055A3 Wax esters in transformed plants |
| 01/04/1996 | WO1995033049A3 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
| 01/04/1996 | WO1995030018A3 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 01/04/1996 | WO1995029193A3 Melanoma antigens |
| 01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |
| 01/04/1996 | DE4423183A1 Prodn. of predetermined nucleotide sequences |
| 01/04/1996 | DE4423131A1 Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4 New hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4 |
| 01/04/1996 | DE4422643A1 New serine protease enzyme from tunicates |
| 01/04/1996 | DE19511243A1 Neuer Wachstums-/Differenzierungsfaktor der TGF-beta-Familie New growth / differentiation factor of the TGF-beta family |
| 01/04/1996 | CA2193954A1 Targeted gene delivery system |
| 01/04/1996 | CA2193952A1 Genetic control of plant hormone levels and plant growth |
| 01/04/1996 | CA2193832A1 Class bi and ci scavenger receptors |
| 01/04/1996 | CA2193827A1 Inducible nitric oxide synthase gene for treatment of disease |
| 01/04/1996 | CA2193812A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof |
| 01/04/1996 | CA2193070A1 Purified polyporus laccases and nucleic acids encoding same |
| 01/04/1996 | CA2192091A1 Heat-stable prolylendopeptidase |
| 01/04/1996 | CA2170156A1 Protocadherin proteins and their uses |
| 01/04/1996 | CA2169953A1 Basic osteoblast growth factor ii (bogf-ii) and methods for producing it |
| 01/03/1996 | EP0690307A1 Method of determining the presence of an autoimmune antibody |
| 01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
| 01/03/1996 | EP0690128A1 Polypeptide having cold-resistant pyruvate phosphate dikinase activity, dna coding for the same, and recombinant vector and transformed plant both containing said dna |
| 01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/03/1996 | EP0690126A1 Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
| 01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 01/03/1996 | EP0689610A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 01/03/1996 | EP0689609A1 Process for typing hla-b using specific primers and probes sets |
| 01/03/1996 | EP0689608A1 Method for determining a metal present in a sample |
| 01/03/1996 | EP0689606A1 ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE |
| 01/03/1996 | EP0689605A1 Hepatitis b escape mutant specific binding molecules |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689603A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |
| 01/03/1996 | EP0689601A1 Production of high titer helper-free retroviruses by transient transfection |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689598A1 Purification and molecular cloning of eg iii cellulase |
| 01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 01/03/1996 | EP0689596A1 Stimulation of immune response by viral protein |
| 01/03/1996 | EP0689595A1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
| 01/03/1996 | EP0689594A1 Dna, dna constructs, cells and plants derived therefrom |
| 01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
| 01/03/1996 | EP0689589A1 Oxidatively stable alpha-amylase |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689587A1 Mutant luciferases |
| 01/03/1996 | EP0689552A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
| 01/03/1996 | EP0689548A1 Human serotonin receptors, dna encoding the receptors, and uses thereof |
| 01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
| 01/03/1996 | EP0689460A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |